NanoViricides Inc. (NNVC)

[JG36]

We got one real serious "bad" -- Ebolacide2 didn't work well enough to warrant proceeding with animal testing. That after NNVC put itself on a "war footing" to save the world with Ebolacide. The only people who called that right were Rawnoc's possibly fictitious sources. We wouldn't be under $2 now if Ebolacide2 had worked.

Then there is the chronic "bad" -- every quarter NNVC drains it's coffers some more. Every quarter takes us closer to the next big share dilution. At under $2 a share that will be mighty ugly.